The short answer
Slippery elm has not been shown to reduce dicyclomine absorption or effectiveness in the reviewed sources. A digestive-health laboratory study did not test medicine absorption or establish a dosing gap.
What this answer covers
Oral dicyclomine with the specific preparation described below.
- Supplement or preparation
- Ulmus rubra
- Medication ingredient
- dicyclomine
Identify the actual slippery elm product
Ulmus rubra products may use different bark preparations, powders, lozenges or mixtures. The plant name alone cannot show whether a proposed binding effect occurs with your product and dose.
The original digestive-health study asked another question
Investigators added herbal preparations to human-derived fecal microbes grown in laboratory cultures. They studied microbial responses, not volunteers taking dicyclomine, drug concentrations or loss of symptom control.
An antacid warning is not proof about bark
Dicyclomine’s label says antacids may interfere with absorption. It does not establish the same interaction for slippery elm merely because both are taken by mouth. A proposed coating or binding mechanism would need relevant testing.
Check timing without inventing an interval
Have a pharmacist review the actual product and other oral medicines. The reviewed study did not validate a one-hour, two-hour or other separation rule for this pair. Do not increase dicyclomine to compensate for an unmeasured effect.
Evidence and practical considerations
Absorption & effectiveness
Slippery elm has not been shown to reduce dicyclomine absorption or effectiveness in the reviewed sources. A digestive-health laboratory study did not test medicine absorption or establish a dosing gap.
- Exact scope
- Oral dicyclomine with the specific preparation described below. with Oral dicyclomine; the hyoscine source, where relevant, is explicitly transdermal.
- Medication form and route
- oral
What remains uncertain
- Ulmus rubra microbial-culture study is not human dosing or drug binding. Exact dicyclomine antacid warning cannot automatically transfer to mucilaginous bark. No clinical magnitude or protective interval established.
Factors that may matter: Exact preparation and amount; Other medicines with overlapping effects; Route and gut-transit status where relevant.
Read the supporting source summaries
Source 1: Current U.S. regulatory product labeling
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral dicyclomine.
Dicyclomine reduces gastrointestinal motility through antimuscarinic effects and can cause dizziness or drowsiness. Other anticholinergic agents may increase actions and adverse effects. Metabolism has not been studied.
How this applies: Exact active ingredient and oral-route context.
Label warnings do not measure every exact supplement pair or provide a universal safe supplement dose or interval.
Source 2: Original laboratory study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Human-derived fecal microbial communities grown in anaerobic laboratory cultures.
The preparations changed microbial populations and fermentation-related measures.
How this applies: A digestive-health laboratory paper does not establish a medication interaction.
Not oral dosing in people, not dicyclomine binding, absorption or efficacy.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Initial source-checked research draft with exact preparation limits, contrary findings and source-access details. Clinical review not recorded. | |
| Research summary published |
Article revision: 79490cdac89fb2a3
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.